Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 15,118.00p on 17-04-2026 at 18:50:06
Change 256.00p 1.72%
Buy 15,102.00p
Sell 15,100.00p
Last Trade: Unknown 6.00 at 15,182.01039p
Day's Volume: 2,867,650
Last Close: 15,118.00p
Open: 14,736.00p
ISIN: GB0009895292
Day's Range 14,736.00p - 15,118.00p
52wk Range: 9,651.00p - 15,730.00p
Market Capitalisation: £234.45b
VWAP: 14,873.97098p
Shares in Issue: 1.55b

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 6 15,182.01039p SI Trade
Currency Conversion
19:01:49 - 17-Apr-26
Unknown* 0 15,182.75022p SI Trade
Currency Conversion
19:00:20 - 17-Apr-26
Unknown* 0 15,184.9697p SI Trade
Currency Conversion
18:59:05 - 17-Apr-26
Unknown* 0 15,176.09176p SI Trade
Currency Conversion
18:59:05 - 17-Apr-26
Unknown* 0 15,174.61211p SI Trade
Currency Conversion
18:57:17 - 17-Apr-26
Unknown* 0 15,157.59606p Currency Conversion
OTC Trade
18:50:12 - 17-Apr-26
Unknown* 2 15,158.32849p Currency Conversion
Negotiated Trade
OTC Trade
18:43:42 - 17-Apr-26
Unknown* 0 15,163.51469p SI Trade
Currency Conversion
18:37:41 - 17-Apr-26
Unknown* 0 15,167.21383p SI Trade
Currency Conversion
18:19:40 - 17-Apr-26
Unknown* 0 15,153.89692p Currency Conversion
OTC Trade
18:12:34 - 17-Apr-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
17th Apr 2026 (Fri) 14,736.00 15,118.00 14,736.00 15,118.00 2,867,650
16th Apr 2026 (Thu) 14,822.00 14,912.00 14,706.00 14,862.00 1,350,676
15th Apr 2026 (Wed) 15,084.00 15,120.00 14,766.00 14,766.00 2,164,561
14th Apr 2026 (Tue) 15,022.00 15,032.00 14,894.00 14,918.00 1,317,948
13th Apr 2026 (Mon) 15,044.00 15,130.00 14,924.00 14,988.00 1,950,720
10th Apr 2026 (Fri) 15,272.00 15,448.00 15,230.00 15,230.00 2,342,279
9th Apr 2026 (Thu) 15,282.00 15,288.00 15,048.00 15,276.00 2,693,782
8th Apr 2026 (Wed) 15,334.00 15,444.00 15,194.00 15,216.00 2,754,215
7th Apr 2026 (Tue) 15,190.00 15,282.00 14,868.00 14,958.00 2,103,198
6th Apr 2026 (Mon) 15,316.00 15,316.00 15,316.00 15,316.00 0
3rd Apr 2026 (Fri) 15,316.00 15,316.00 15,316.00 15,316.00 0
2nd Apr 2026 (Thu) 15,042.00 15,436.00 14,956.00 15,316.00 1,608,903
1st Apr 2026 (Wed) 14,896.00 15,100.00 14,868.00 15,022.00 2,678,542
31st Mar 2026 (Tue) 14,710.00 14,856.00 14,660.00 14,690.00 2,535,823
30th Mar 2026 (Mon) 14,438.00 14,752.00 14,322.00 14,702.00 2,270,252
27th Mar 2026 (Fri) 14,114.00 14,508.00 14,006.00 14,302.00 2,680,598
26th Mar 2026 (Thu) 13,922.00 13,982.00 13,768.00 13,830.00 2,338,587
25th Mar 2026 (Wed) 13,930.00 14,080.00 13,842.00 14,062.00 1,560,595
24th Mar 2026 (Tue) 13,728.00 13,856.00 13,646.00 13,810.00 1,399,857
23rd Mar 2026 (Mon) 13,694.00 13,938.00 13,480.00 13,742.00 2,143,472
20th Mar 2026 (Fri) 14,090.00 14,216.00 13,884.00 13,896.00 4,172,253
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
9th Apr 2026 5:15 pm RNS Result of AGM
2nd Apr 2026 7:00 am RNS Imfinzi+Imjudo improves PFS in early liver cancer
1st Apr 2026 3:00 pm RNS Total Voting Rights and Admission of Shares
31st Mar 2026 7:00 am RNS Efzimfotase alfa Ph3 program show positive results
27th Mar 2026 7:00 am RNS Tozorakimab met OBERON/TITANIA primary endpoints
20th Mar 2026 11:00 am RNS Notification of Admission of Shares
16th Mar 2026 7:00 am RNS Imfinzi approved in EU for early gastric cancer
16th Mar 2026 7:00 am RNS Imfinzi approved in EU for early gastric cancer
10th Mar 2026 11:00 am RNS Notice of AGM
10th Mar 2026 11:00 am RNS Notice of AGM
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

LONDON BROKER RATINGS: Berenberg says 'buy' Elixirr International

10th Apr 2026 09:11

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

UK shareholder meetings calendar - next 7 days

2nd Apr 2026 12:07

Read More

AstraZeneca hails encouraging data for liver cancer drug regimen

2nd Apr 2026 10:46

(Alliance News) - AstraZeneca PLC on Thursday posted encouraging phase-three trial results for its liver cancer treatment combination. Read More

AstraZeneca says hypophosphatasia replacement enzyme trials positive

31st Mar 2026 10:03

(Alliance News) - AstraZeneca PLC on Tuesday said phase-three testing of its replacement efzimfotase alfa enzyme on patients affected by hypophosphatasia yielded positive safety and efficacy results. Read More

LONDON MARKET CLOSE: FTSE 100 ends down as oil rises amid war deadlock

27th Mar 2026 17:07

(Alliance News) - Blue chips in London outperformed European and US peers on Friday, but closed marginally lower, as oil prices rose once more amid few signs of progress in ending the Iran war. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,667.63
Change77.64

Login to your account

Forgot Password?

Not Registered